The corresponding/leading author's share in Canadian immunology publications shows a slight but consistent decline from 2024 to 2028, moving from 89.94% to 89.74%. Since we are currently in 2024, 2023's data serves as a baseline for analyzing forecasts, emphasizing the stability but gently decreasing trend.
Notably, these figures reflect a minor year-on-year decline, with a consistent trajectory observed over the forecasted period. Although the changes are subtle, they suggest a potential shift in collaborative practices or authorship norms within the scientific community.
Future trends to watch for include shifts toward more collaborative or international research efforts that may further reduce the dominance of leading authors, alongside advancements in research dissemination and open-access trends that could impact author share dynamics.
